In this study, we identified SGK1 as a downstream of DLEU2; the results were confirmed in prostate cancer cells and in TCGA dataset, indicating that SGK1 expression was strongly suppressed by DLEU2 knockdown. This evidence concerns the gene DLEU2 and prostate carcinoma.